Atrial Fibrillation Versus Nonatrial Fibrillation Coronary Embolism: A Multicenter Study

Atrial Fibrillation

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Circulation

Al Said S, Braunwald E, Palazzolo MG, Melloni GEM, Geller BJ, Ruff CT, Antman EM, Carnicelli AP, Eikelboom J, Granger CB, Patel MR, Wallentin L, Giugliano RP

doi: 10.1161/CIRCULATIONAHA.125.075275

Atrial Fibrillation

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Circulation

Oldgren J, Hijazi Z, Arheden H, Björkenheim A, Frykman V, Janzon M, Ravn-Fischer A, Renlund H, Själander A, Åkerfeldt T, Wallentin L

doi: 10.1161/CIRCULATIONAHA.125.076725

Atrial FibrillationThrombosis and Stroke

Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry

Eur Heart J

Castrejón-Castrejón S, Heeger CH, Veltmann C, Schaack D, Nies M, Gunawardene M, Steven D, Tscholl V, Roten L, Sommer P, Spartalis M, Seitz J, Kistler PM, Chen M, Wang Q, Del-Carpio Munoz F, Wijnmaalen AP, Moreno J, Albarrán-Rincón R, Sanders P, Blessberger H, Laredo M, Krahnefeld O, Pernat A, Guenancia C, Aro A, Castellanos Martínez E, Scazzuso F, Sticherling C, Neven K, Yorgun H, Choi JI, Natale A, Almorad A, Joung B, Wichterle D, Ruwald MH, Cay S, Andorin A, Kato H, Carnero G, Maciag A, Garkina S, Deharo JC, Sadek MM, Iwasaki YK, Beiert T, Choi EK, Kojic D, Sousa J, Bergau L, Lellouche N, Arabia Cortés L, Camargo JM, Inaba O, Szegedi N, Piccini JP, Marijon E, Mazurek M, Sandgaard NCF, Francke A, Schumacher B, Adams Sánchez CD, Stiles MK, García-Izquierdo E, Ramos Jiménez J, Guerra JM, Aboulmaaty M, Jansen H, Metzner A, Zapata García C, Ruiz Ares G, Pürerfellner H, Kyoung-Ryul Chun J, Merino JL, EMBOL-AF investigators

doi: 10.1093/eurheartj/ehag217

Atrial Fibrillation

Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: Insights from a multicenter study

Heart Rhythm

Mohanty S, Torlapati PG, Casella M, La Fazia VM, Valeri Y, Gianni C, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton R, Allison J, Bode W, Di Biase L, Russo AD, Natale A

doi: 10.1016/j.hrthm.2025.03.1952

Atrial Fibrillation

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Am Heart J

Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S

doi: 10.1016/j.ahj.2026.107367

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial FibrillationHeart, Artery and Coronary Diseases

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

JAMA Cardiol

Yamaguchi J, Arashi H, Hagiwara N, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Matsui K, Ogawa H, AFIRE Investigators

doi: 10.1001/jamacardio.2025.2611

Atrial Fibrillation

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Am Heart J

Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G, Lucci D, Marin F, Potpara TS, Sanaullah A, Tokmakova M, Johnsen SP, Maggioni AP, AFFIRMO Study Investigators and Consortium

doi: 10.1016/j.ahj.2026.107356

Related content

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry

Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: Insights from a multicenter study

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial